Tianxin Ye

403 total citations
21 papers, 305 citations indexed

About

Tianxin Ye is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Tianxin Ye has authored 21 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Tianxin Ye's work include Cardiac electrophysiology and arrhythmias (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Tianxin Ye is often cited by papers focused on Cardiac electrophysiology and arrhythmias (7 papers), Atrial Fibrillation Management and Outcomes (6 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). Tianxin Ye collaborates with scholars based in China and Japan. Tianxin Ye's co-authors include Cui Zhang, Bo Yang, Chuan Qu, Xin Liu, Shaobo Shi, Weiguo Wan, Yan Guo, Jinjun Liang, Gang Wu and Qian Ran and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Tianxin Ye

20 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianxin Ye China 12 172 117 35 32 23 21 305
Chuan Qu China 14 212 1.2× 128 1.1× 47 1.3× 25 0.8× 34 1.5× 30 380
Hanlai Zhang China 8 183 1.1× 68 0.6× 14 0.4× 27 0.8× 17 0.7× 10 398
Tianyu Meng China 10 135 0.8× 40 0.3× 19 0.5× 18 0.6× 31 1.3× 15 328
Mengwei Sun China 11 192 1.1× 91 0.8× 16 0.5× 32 1.0× 6 0.3× 13 441
Christopher Morrell United States 7 121 0.7× 142 1.2× 10 0.3× 15 0.5× 18 0.8× 12 330
Mengli Chen China 10 125 0.7× 57 0.5× 30 0.9× 9 0.3× 8 0.3× 20 300
Maria D. Dănilă Romania 9 122 0.7× 67 0.6× 10 0.3× 71 2.2× 9 0.4× 16 325
Tianqi Tao China 12 179 1.0× 60 0.5× 9 0.3× 42 1.3× 9 0.4× 32 353
Hanaa N. Al‐Ajmi Saudi Arabia 8 141 0.8× 79 0.7× 6 0.2× 50 1.6× 10 0.4× 8 386
Junpeng Long China 9 184 1.1× 31 0.3× 15 0.4× 18 0.6× 9 0.4× 14 323

Countries citing papers authored by Tianxin Ye

Since Specialization
Citations

This map shows the geographic impact of Tianxin Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianxin Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianxin Ye more than expected).

Fields of papers citing papers by Tianxin Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianxin Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianxin Ye. The network helps show where Tianxin Ye may publish in the future.

Co-authorship network of co-authors of Tianxin Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Tianxin Ye. A scholar is included among the top collaborators of Tianxin Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianxin Ye. Tianxin Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Tianxin, et al.. (2025). Inhibition of P2X7 receptor mitigates atrial fibrillation susceptibility in isoproterenol-induced rats. Biochemical and Biophysical Research Communications. 749. 151340–151340.
2.
Ye, Tianxin, Cui Zhang, Bo Yang, et al.. (2025). TRPV2 Inhibition Prevents Right Ventricular Remodeling and Arrhythmia in Experimental Pulmonary Hypertension. The FASEB Journal. 39(16). e70949–e70949. 1 indexed citations
3.
Ye, Tianxin, et al.. (2024). P2X7 receptor inhibition prevents atrial fibrillation in rodent models of depression. EP Europace. 26(2). 11 indexed citations
4.
Ye, Tianxin, Jinxiu Yang, Yi Yu, et al.. (2024). Inhibition of the P2X7 receptor prevents atrial proarrhythmic remodeling in experimental post-operative atrial fibrillation. International Immunopharmacology. 129. 111536–111536. 4 indexed citations
5.
Ye, Tianxin, Yi Yu, Yanan Chu, et al.. (2023). TRPV2 inhibitor tranilast prevents atrial fibrillation in rat models of pulmonary hypertension. Cell Calcium. 117. 102840–102840. 5 indexed citations
6.
Chen, Xiaoli, Weiguo Wan, Qian Ran, et al.. (2022). Pinocembrin mediates antiarrhythmic effects in rats with isoproterenol-induced cardiac remodeling. European Journal of Pharmacology. 920. 174799–174799. 21 indexed citations
7.
Ran, Qian, Xiaoli Chen, Cui Zhang, et al.. (2022). Pinocembrin Decreases Atrial Fibrillation Susceptibility in a Rodent Model of Depression. Frontiers in Cardiovascular Medicine. 9. 766477–766477. 6 indexed citations
8.
Wan, Weiguo, Tianxin Ye, Xiaoli Chen, et al.. (2022). Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension. Bioengineered. 13(4). 10843–10856. 8 indexed citations
9.
Shi, Shaobo, Xin Liu, Tianxin Ye, et al.. (2021). Retrospective cohort study of new-onset atrial fibrillation in acute pulmonary embolism on prognosis. BMJ Open. 11(9). e047658–e047658. 9 indexed citations
10.
Wan, Weiguo, Tianxin Ye, Xiaoli Chen, et al.. (2021). Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathway. Life Sciences. 277. 119418–119418. 28 indexed citations
11.
Wan, Weiguo, Yan Guo, Tianxin Ye, et al.. (2021). Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway. Molecular Medicine. 27(1). 100–100. 41 indexed citations
12.
Ye, Tianxin, Cui Zhang, Gang Wu, et al.. (2020). Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of Depression. Frontiers in Pharmacology. 11. 547966–547966. 20 indexed citations
13.
Zhang, Cui, Yan Guo, Xin Liu, et al.. (2020). Chronic stimulation of the sigma-1 receptor ameliorates ventricular ionic and structural remodeling in a rodent model of depression. Life Sciences. 257. 118047–118047. 13 indexed citations
14.
Guo, Yan, Cui Zhang, Xin Liu, et al.. (2020). Sigma-1 receptor ligands improves ventricular repolarization-related ion remodeling in rats with major depression disorder. Psychopharmacology. 238(2). 487–499. 7 indexed citations
15.
Zhang, Cui, Xin Liu, Tianxin Ye, et al.. (2020). Chronic sigma-1 receptor activation ameliorates ventricular remodeling and decreases susceptibility to ventricular arrhythmias after myocardial infarction in rats. European Journal of Pharmacology. 889. 173614–173614. 21 indexed citations
16.
17.
Liu, Xin, Chuan Qu, Shaobo Shi, et al.. (2019). The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism. Frontiers in Physiology. 10. 1346–1346. 16 indexed citations
18.
Ye, Tianxin, Cui Zhang, Gang Wu, et al.. (2019). Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction. International Immunopharmacology. 77. 105926–105926. 42 indexed citations
19.
Ye, Tianxin, Xin Liu, Chuan Qu, et al.. (2019). Chronic inhibition of the sigma-1 receptor exacerbates atrial fibrillation susceptibility in rats by promoting atrial remodeling. Life Sciences. 235. 116837–116837. 21 indexed citations
20.
Qu, Chuan, Xin Liu, Tianxin Ye, et al.. (2019). miR‑216a exacerbates TGF‑β‑induced myofibroblast transdifferentiation via PTEN/AKT signaling. Molecular Medicine Reports. 19(6). 5345–5352. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuan Qu Breakdown of academic impact, for papers by Hanlai Zhang Breakdown of academic impact, for papers by Tianyu Meng Breakdown of academic impact, for papers by Mengwei Sun Breakdown of academic impact, for papers by Christopher Morrell Breakdown of academic impact, for papers by Mengli Chen Breakdown of academic impact, for papers by Maria D. Dănilă Breakdown of academic impact, for papers by Tianqi Tao Breakdown of academic impact, for papers by Hanaa N. Al‐Ajmi Breakdown of academic impact, for papers by Junpeng Long
Rankless by CCL
2026